Fundraising Fox

Laurent Fischer

Investor

Director; Chair Science and Technology Committee; Member Compensation Committee at atai Life Sciences

San Francisco, California, United States

About

Laurent Fischer is CEO and President of Adverum Biotechnologies and sits on the boards of Mirum Pharmaceuticals, Lycia Therapeutics, and Teal. He previously chaired CTI Biopharma, led Tobira Therapeutics as CEO (later acquired by Allergan), and held leadership positions at Jennerex, RXCentric, MedVantx, Dupont Pharmaceuticals, Dupont-Merck, and F. Hoffmann-La Roche. He holds an undergraduate degree from the University of Geneva and a medical degree from the Geneva Medical School in Switzerland.

Invests in

Biotech

Experience

  1. Shinobi TherapeuticsChairman of the Boardcurrent2025 β€” present
  2. AtaiBeckleyIndependent Directorcurrent2024 β€” present
  3. Lycia TherapeuticsIndependent Directorcurrent2019 β€” presentSan Francisco Bay Area
  4. Mirum PharmaceuticalsBoard Of Directorscurrent2019 β€” presentSan Mateo, California
  5. Adverum Biotechnologies, Inc.President and Chief Executive Officer2020 β€” 2025Redwood City, California, United States
  6. Teal OmicsChair2023 β€” 2025Palo Alto, California, United States
  7. CTI BioPharmaChairman Of The Board2017 β€” 2023Seattle, Washington, United States
  8. Senti BiosciencesBoard Member2019 β€” 2020San Francisco Bay Area
  9. AllerganLiver Therapeutic Area Head, Senior Vice President2016 β€” 2020San Francisco Bay Area
  10. Tobira TherapeuticsChief Executive Officer2010 β€” 2016South San Francisco
  11. Tobira TherapeuticsDirector, Executive Chairman, Interim CEO2009 β€” 2010
  12. Jennerex BiotherapeuticsChairman and CEO2013 β€” 2014San Francisco Bay Area
  13. Jennerex BiotherapeuticsPresident and CEO2012 β€” 2014San Francisco Bay Area
  14. AIDS Healthcare FoundationBoard member2001 β€” 2012Greater Los Angeles Area
  15. Ocera Therapeutics, Inc.Founder and Chief Executive Officer2005 β€” 2012San Diego
  16. TelormedixConsultant2009
  17. Auxeris TherapeuticsPresident and CEO2003 β€” 2005
  18. MedVantxCMO and VP of Corporate Development2001 β€” 2003
  19. DuPont PharmaceuticalsSr Vice President, Global Virology Group1997 β€” 2000
  20. Hoffmann-La RocheMedical Director1993 β€” 1997

Education

  1. University of GenevaM.D., Medicine1982 β€” 1989

Skills & more

CTMS2Virology18Pharmaceutical Industry54Clinical Trials29Drug Development77Clinical Development65Biotechnology65Oncology25Infectious Diseases20Lifesciences20Biopharmaceuticals42Medical Devices11
+12 moreRegulatory AffairsCardiologyClinical ResearchStart-upsVenture CapitalCommercializationFDATechnology TransferLicensingSenior Executive LeadershipImmunologyHealthcare

From Laurent's professional profile.

Investments

Board seats

Lycia TherapeuticsMirum Pharmaceuticals, Inc.Teal

Per the firm's website.

Colleagues at atai Life Sciences

Frequently asked questions

Where does Laurent Fischer work?
Laurent Fischer is Director; Chair Science and Technology Committee; Member Compensation Committee at atai Life Sciences.
What does Laurent Fischer invest in?
Laurent Fischer invests in Biotech.

Same school

Shared employers